Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
2007 1
2010 1
2011 1
2012 2
2014 1
2016 2
2017 3
2018 6
2019 10
2020 12
2021 7
2022 9
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
Welch SR, Spengler JR, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Scholte FEM, Rodriguez SE, O'Neal TJ, Ritter JM, Ficarra G, Davies KA, Kainulainen MH, Karaaslan E, Bergeron É, Goldsmith CS, Lo MK, Nichol ST, Montgomery JM, Spiropoulou CF. Welch SR, et al. Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057. Epub 2023 Aug 4. Sci Adv. 2023. PMID: 37540755 Free PMC article.
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.
Durie IA, Tehrani ZR, Karaaslan E, Sorvillo TE, McGuire J, Golden JW, Welch SR, Kainulainen MH, Harmon JR, Mousa JJ, Gonzalez D, Enos S, Koksal I, Yilmaz G, Karakoc HN, Hamidi S, Albay C, Spengler JR, Spiropoulou CF, Garrison AR, Sajadi MM, Bergeron É, Pegan SD. Durie IA, et al. Among authors: welch sr. Nat Commun. 2022 Nov 26;13(1):7298. doi: 10.1038/s41467-022-34923-0. Nat Commun. 2022. PMID: 36435827 Free PMC article.
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions.
Scholte FEM, Karaaslan E, O'Neal TJ, Sorvillo TE, Genzer SC, Welch SR, Coleman-McCray JD, Spengler JR, Kainulainen MH, Montgomery JM, Pegan SD, Bergeron E, Spiropoulou CF. Scholte FEM, et al. Among authors: welch sr. Front Cell Infect Microbiol. 2023 Aug 21;13:1233148. doi: 10.3389/fcimb.2023.1233148. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37671145 Free PMC article.
Inhibition of Nipah Virus by Defective Interfering Particles.
Welch SR, Tilston NL, Lo MK, Whitmer SLM, Harmon JR, Scholte FEM, Spengler JR, Duprex WP, Nichol ST, Spiropoulou CF. Welch SR, et al. J Infect Dis. 2020 May 11;221(Suppl 4):S460-S470. doi: 10.1093/infdis/jiz564. J Infect Dis. 2020. PMID: 32108876 Free PMC article.
Sensitivity to BST-2 restriction correlates with Orthobunyavirus host range.
Varela M, Piras IM, Mullan C, Shi X, Tilston-Lunel NL, Pinto RM, Taggart A, Welch SR, Neil SJD, Kreher F, Elliott RM, Palmarini M. Varela M, et al. Among authors: welch sr. Virology. 2017 Sep;509:121-130. doi: 10.1016/j.virol.2017.06.017. Epub 2017 Jun 17. Virology. 2017. PMID: 28628828 Free PMC article.
70 results